{"schema_version":"1","generated_at":"2026-11-21T22:23:24.486Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anthony-abner","json_url":"https://www.findmykol.com/kol/anthony-abner/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anthony-abner","name":"Anthony Abner","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Mount Auburn Hospital","institution_url":"https://www.findmykol.com/institution/mount-auburn-hospital","city":"Cambridge","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Anthony Abner is an Oncology physician affiliated with Mount Auburn Hospital. OpenAlex indexes 53 publications with 4,213 citations (h-index 22).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":53,"cited_by_count":4213,"h_index":22,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Boston Scientific Corporation","program_year":2025,"amount_usd":38.23,"payment_count":1},{"payer":"Boston Scientific Corporation","program_year":2023,"amount_usd":21.59,"payment_count":1},{"payer":"Boston Scientific Corporation","program_year":2022,"amount_usd":21.31,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":5,"areas_shown":3,"areas":[{"area":"Genitourinary & hormones","share_pct":61.8,"classes_total":2,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":52.1,"drugs":[{"name":"Tamsulosin Hcl","share_pct":86.3},{"name":"Alfuzosin Hcl Er","share_pct":13.7}],"max_beneficiaries":null},{"class":"Phosphodiesterase 5 Inhibitor","setting":"prescribed","share_pct":9.7,"drugs":[{"name":"Sildenafil Citrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":19.9,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":14.2,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":13},{"class":"Benzodiazepine","setting":"prescribed","share_pct":5.6,"drugs":[{"name":"Lorazepam","share_pct":100}],"max_beneficiaries":13}]},{"area":"Cancer & immunology","share_pct":7.5,"classes_total":1,"classes":[{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":7.5,"drugs":[{"name":"Bicalutamide","share_pct":100}],"max_beneficiaries":19}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Regarding Sequencing of Androgen-Deprivation Therapy","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.02824","status":"verified"},{"title":"Eccrine Carcinoma With an Unknown Primary: Managing Occult Cancer Through Multidisciplinary Tumor Board Collaboration","year":2022,"journal":"Cureus","source_url":"https://doi.org/10.7759/cureus.23183","status":"verified"},{"title":"Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer","year":2005,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2004.06.011","status":"verified"},{"title":"LIMITATIONS IN THE USE OF SERUM PROSTATE SPECIFIC ANTIGEN LEVELS TO MONITOR PATIENTS AFTER TREATMENT FOR PROSTATE CANCER","year":2005,"journal":"The Journal of Urology","source_url":"https://doi.org/10.1097/01.ju.0000157323.55611.23","status":"verified"},{"title":"Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy","year":2005,"journal":"Urologic Oncology Seminars and Original Investigations","source_url":"https://doi.org/10.1016/j.urolonc.2005.02.005","status":"verified"}],"source":"works"},"similar":[{"name":"Binu Philips","slug":"binu-philips","institution":"Mount Auburn Hospital","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/binu-philips","json_url":"https://www.findmykol.com/kol/binu-philips/profile.json"},{"name":"Peter Rosenblatt","slug":"peter-rosenblatt","institution":"Mount Auburn Hospital","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/peter-rosenblatt","json_url":"https://www.findmykol.com/kol/peter-rosenblatt/profile.json"},{"name":"Ayse Sahin-Efe","slug":"ayse-sahin-efe","institution":"Mount Auburn Hospital","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/ayse-sahin-efe","json_url":"https://www.findmykol.com/kol/ayse-sahin-efe/profile.json"},{"name":"Stephen Zinner","slug":"stephen-zinner","institution":"Mount Auburn Hospital","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/stephen-zinner","json_url":"https://www.findmykol.com/kol/stephen-zinner/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}